Related Experiment Video
Updated: Aug 23, 2025

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
Published on: July 6, 2013
Salmonella as a Promising Curative Tool against Cancer
Ram Prasad Aganja1, Chandran Sivasankar1, Amal Senevirathne2
1Department of Veterinary Public Health, College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Korea.
Abstract:
Bacteria-mediated cancer therapy has become a topic of interest under the broad umbrella of oncotherapy. Among many bacterial species, Salmonella remains at the forefront due to its ability to localize and proliferate inside tumor microenvironments and often suppress tumor growth. Salmonella Typhimurium is one of the most promising mediators, with engineering plasticity and cancer specificity. It can be used to deliver toxins that induce cell death in cancer cells specifically, and also as a cancer-specific instrument for immunotherapy by delivering tumor antigens and exposing the tumor environment to the host immune system. Salmonella can be used to deliver prodrug converting enzymes unambiguously against cancer. Though positive responses in Salmonella-mediated cancer treatments are still at a preliminary level, they have paved the way for developing combinatorial therapy with conventional chemotherapy, radiotherapy, and surgery, and can be used synergistically to combat multi-drug resistant and higher-stage cancers. With this background, Salmonella-mediated cancer therapy was approved for clinical trials by U.S. Food and Drug Administration, but the results were not satisfactory and more pre-clinical investigation is needed. This review summarizes the recent advancements in Salmonella-mediated oncotherapy in the fight against cancer. The present article emphasizes the demand for Salmonella mutants with high stringency toward cancer and with amenable elements of safety by virulence deletions.
Insights
Salmonella bacteria show promise in cancer therapy by targeting tumors and aiding immunotherapy. Further research is needed to improve safety and efficacy for clinical use in treating various cancers.
Area of Science:
- Oncology
- Microbiology
- Immunotherapy
Background:
- Bacteria-mediated cancer therapy, particularly using *Salmonella*, is a growing field in oncotherapy.
- *Salmonella* Typhimurium exhibits tumor-specific localization and proliferation, offering potential for targeted cancer treatment.
- Its plasticity allows for engineering to deliver toxins, antigens, or prodrug-converting enzymes, enhancing cancer cell death and immune response.
Purpose of the Study:
- To review recent advancements in *Salmonella*-mediated oncotherapy.
- To highlight the potential of *Salmonella* in combinatorial cancer treatments.
- To emphasize the need for developing safer and more cancer-specific *Salmonella* mutants.
Main Methods:
- Review of current literature on *Salmonella*-mediated cancer therapy.
- Analysis of *Salmonella*'s mechanisms in targeting tumor microenvironments.
- Evaluation of preclinical and clinical trial data for *Salmonella*-based cancer treatments.
Main Results:
- *Salmonella* demonstrates potential in delivering therapeutic agents directly to tumors.
- Engineered *Salmonella* can enhance both direct cancer cell killing and host anti-tumor immunity.
- Combinatorial approaches with conventional therapies show promise for resistant and advanced cancers.
Conclusions:
- *Salmonella*-mediated therapy holds significant promise but requires further preclinical investigation for improved safety and efficacy.
- Development of *Salmonella* mutants with enhanced cancer specificity and deletions in virulence factors is crucial.
- Future research should focus on optimizing *Salmonella* delivery systems and understanding host-pathogen interactions in the tumor microenvironment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...

